Newcastle Hospitals is one of the busiest and largest NHS hospital trusts in the country. We have around 16,000 staff and an annual budget of £1.7 billion.
With strong history of providing high quality care, clinical excellence, research and innovation regionally, nationally and internationally, we’re in the top five providers of specialised health services in the country.
As well as providing a wide range of hospital and community services, we support people with a range of rare and complex medical, surgical and neurological conditions, cancers and genetic orders.
With around 2 million contacts with patients every year, we deliver care from:
- Royal Victoria Infirmary (RVI)
- Freeman Hospital
- Newcastle Dental Hospital
- Cramlington Manor Walks
- Urgent treatment centres
- Newcastle Fertility Centre
- Northern Centre for Cancer Care, North Cumbria
- Northern Genetics Service
Our clinical services are structured and organised through eight clinical boards:
- Family health
- Medicine and emergency care
- Surgical and specialist services (mainly RVI)
- Surgical and associated services (mainly Freeman)
- Perioperative and critical care
- Cancer and haematology
- Cardiothoracic services
- Clinical and research services
Each board has responsibility for strategy, performance, workforce and finance in their area, covering a range of specialities and sub-specialities.
Leaders in research, innovation and pioneering treatments
As leaders in healthcare research and development across a wide range of specialisms, much of our clinical work and services are underpinned by a world-class programme of research and innovation.
Our research is only possible through the important partnerships we also have with patients, other NHS organisations, universities, the local authority and charitable bodies. Our partnership with Newcastle University has a strong focus on clinical research, allowing us stay the forefront of developing pioneering treatment and care.
We belong to the north east’s NIHR Healthtech Research Centre (HRCs) and work with Diagnostics North East as part of a strategic partnership which brings together the various components of a unique and innovative infrastructure to aid diagnostic development.
Through our North East Innovation Lab, we work with developers from across the world to evaluate and validate new diagnostic products. This includes assessing their performance using our extensive biobank of clinical samples, on their journey to mainstream use.
